We are live on ! Find out more
RI

RTW Investments Portfolio holdings

AUM $10B
1-Year Est. Return 135.35%
This Fund
S&P 500
This Quarter Est. Return
+25.27%
1 Year Est. Return
+135.35%
3 Year Est. Return
+383.62%
5 Year Est. Return
+523.94%
10 Year Est. Return
+15,981.64%
AUM
$474M
AUM Growth
+$94.5M
Cap. Flow
+$37.7M
Cap. Flow %
7.94%
Top 10 Hldgs %
76.63%
Holding
34
New
6
Increased
17
Reduced
4
Closed
6

Top Buys

Rank Stock Value
1
PTCT icon
PTC Therapeutics
PTCT
+$26.9M
2
ABUS icon
Arbutus Biopharma
ABUS
+$12.9M
3
BMY icon
Bristol-Myers Squibb
BMY
+$11.1M
4
ACHN
Achillion Pharmaceuticals
ACHN
+$6.39M
5
OMER icon
Omeros
OMER
+$4.14M

Top Sells

Rank Stock Value
1
MDCO
Medicines Co
MDCO
+$28M
2
INCY icon
Incyte
INCY
+$11M
3
IVTY
Invuity, Inc
IVTY
+$3.47M
4
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$3.32M
5
AVXS
AveXis, Inc. Common Stock
AVXS
+$2.72M

Sector Composition

Rank Sector Weight
1 Healthcare 97.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARGX icon
26
argenx
ARGX
$55.2B
$530K 0.11%
+24,970
New +$520K
IVTY
27
DELISTED
Invuity, Inc
IVTY
$173K 0.04%
23,830
-446,337
-95% -$3.47M
SRTSW
28
DELISTED
Sensus Healthcare, Inc. Warrant expiring on 06/08/2020
SRTSW
$93K 0.02%
155,000
– –
CLDX icon
29
Celldex Therapeutics
CLDX
$2.94B
– –
-16,113
Closed -$873K
INCY icon
30
Incyte
INCY
$25.4B
– –
-82,490
Closed -$11M
NTRA icon
31
Natera
NTRA
$36.4B
– –
-31,693
Closed -$281K
SRTS icon
32
Sensus Healthcare
SRTS
$46.9M
– –
-90,404
Closed -$397K
TMBR
33
DELISTED
Timber Pharmaceuticals, Inc.
TMBR
– –
-86
Closed -$648K
MDCO
34
DELISTED
Medicines Co
MDCO
– –
-572,689
Closed -$28M
1
2

Similar funds

LWCFA
Loring Wolcott & Coolidge Fiduciary Advisors Boston, Massachusetts $9.98B AUM 4.97% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return
IIM
INTECH Investment Management West Palm Beach, Florida $10.2B AUM 28.14% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
FPAS
Focus Partners Advisor Solutions Saint Louis, Missouri $9.92B AUM 21.52% 1-Year Est. Return
VPIM
Vanguard Personalized Indexing Management Oakland, California $10.2B AUM 34.45% 1-Year Est. Return

RTW Investments's Q2 2017 Portfolio in Review

As of Q2 2017, RTW Investments held 34 positions worth $474M, up 25% from $380M the previous quarter. Its ten largest holdings account for 77% of the portfolio.

RTW Investments deployed $37.7M of net new capital in Q2 2017, opening 6 new positions and adding to 17 existing holdings. Its largest new stake was Achillion Pharmaceuticals: 1,590,454 shares worth $7.3M.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, up from 90% a quarter earlier.

On the sell side, the largest reduction was Invuity, Inc, an estimated $3.47M trimmed.

  • RTW Investments's largest Q2 2017 buy was Achillion Pharmaceuticals: 1,590,454 shares worth $7.3M.
  • RTW Investments added most to PTC Therapeutics in Q2 2017, an estimated $26.9M increase.
  • RTW Investments's biggest Q2 2017 reduction was Invuity, Inc, cutting an estimated $3.47M.
  • RTW Investments fully exited Medicines Co in Q2 2017, selling an estimated $28M.
  • RTW Investments's ten largest holdings make up 77% of its $474M portfolio in Q2 2017.
  • RTW Investments opened 6 new positions and closed 6 in Q2 2017.
  • RTW Investments's portfolio value rose 25% quarter-over-quarter to $474M.

Based on RTW Investments's 13F filing for Q2 2017, filed 14 Aug 2017.